Physician

Amjad Almahameed, M.D., M.P.H.

According to 2025 Medicare claims, Amjad Almahameed, M.D., M.P.H. (NPI: 1780793828) practices interventional cardiology in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from Mecklenburg, NC. This provider's primary affiliated billing organization is THE PRESBYTERIAN HOSPITAL (NPI: 1811610058; TIN: 560554230) and primary practice location at 28204-2515. Almahameed is affiliated with the IHC Quality Partners, LLC (ACO ID: A2833) and Novant Health Accountable Care Organization I, LLC (ACO ID: A3504), participating under the MSSP model.

Almahameed's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 219 traditional Medicare patients, billed 706 HCPCS/CPT codes, and received $71,062 in Medicare payments. The top billing code was 93458 (Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist). Part D data shows 1,728 prescription claims across 269 beneficiaries totaling $349,586 in drug costs, led by Eliquis (Apixaban). 2017 DME data shows 12 claims. Open Payments data shows 47 records totaling $908. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $46,472 to $71,062. Similarly, Part D prescription costs have moved sharply higher in recent years, from $7,408 to $349,586. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	116	189	$46,472
2016	328	668	$39,717
2017	409	814	$59,948
2018	424	927	$95,871
2019	589	1,412	$139,808
2020	415	1,127	$124,785
2021	455	1,148	$129,879
2022	383	945	$107,370
2023	266	885	$99,103
2024	219	706	$71,062

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	37	123	$7,408
2016	36	105	$7,492
2017	118	713	$52,938
2018	141	716	$51,532
2019	214	1,086	$106,937
2020	216	1,109	$132,830
2021	233	1,410	$206,137
2022	229	1,474	$251,095
2023	257	1,501	$269,963
2024	269	1,728	$349,586

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	12	$25,276
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93458	Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist	53	56	$172
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	33	34	$129
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	71	88	$99
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	70	91	$66
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	94	104	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	74	4,020	$78,402
Farxiga	Dapagliflozin Propanediol	57	2,850	$52,990
Repatha Sureclick	Evolocumab	67	2,548	$49,393
Xarelto	Rivaroxaban	49	2,921	$48,340
Brilinta	Ticagrelor	67	2,430	$35,167

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	47	$908	Kestra Medical Technology Services, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amjad Almahameed, M.D., M.P.H.?

Tedicare shows public-source Medicare data for Amjad Almahameed, M.D., M.P.H. (NPI 1780793828), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amjad Almahameed, M.D., M.P.H. have ACO affiliation data?

Amjad Almahameed, M.D., M.P.H. is shown with ACO affiliation data for IHC Quality Partners, LLC (MSSP, ACO ID A2833) and Novant Health Accountable Care Organization I, LLC (MSSP, ACO ID A3504).

What billing organization is linked to Amjad Almahameed, M.D., M.P.H.?

Amjad Almahameed, M.D., M.P.H. is linked to THE PRESBYTERIAN HOSPITAL (billing NPI 1811610058) in the available physician profile data.

Does Amjad Almahameed, M.D., M.P.H. have Open Payments data?

Amjad Almahameed, M.D., M.P.H. has 47 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.